PCIA
XTJA icon

Prime Capital Investment Advisors’s Innovator US Equity Accelerated Plus ETF January XTJA Stock Holding History

Prime Capital Investment Advisors’s Portfolio XTJA Stock Details XTJA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Buy
+10,000
New +$332K ﹤0.01% 824

Other funds holding XTJA

HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
SIA
Soltis Investment Advisors St. George, Utah $1.8B AUM 27.41% 1-Year Est. Return
BBPWM
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $802M AUM 22.13% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return
DFA
DHJJ Financial Advisors Naperville, Illinois $347M AUM 22.07% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Prime Capital Investment Advisors's XTJA Position: Q2 2026 in Review

Prime Capital Investment Advisors opened a new position in Innovator US Equity Accelerated Plus ETF January (XTJA) in Q2 2026: 10,000 shares worth $340K. The stake represents ﹤0.01% of the portfolio and ranks #824 among its holdings.

9 funds tracked by Wall St. Rank hold XTJA as of Q2 2026.

  • Prime Capital Investment Advisors held 10,000 shares of Innovator US Equity Accelerated Plus ETF January worth $340K as of Q2 2026.
  • Innovator US Equity Accelerated Plus ETF January was a new Prime Capital Investment Advisors position in Q2 2026.
  • Innovator US Equity Accelerated Plus ETF January made up ﹤0.01% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #824 holding.
  • 9 funds tracked by Wall St. Rank held Innovator US Equity Accelerated Plus ETF January as of Q2 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.